Yes, I think he said the IND had just been filed. Also interesting was that the halflife of CX-701 is almost twice as long as CX-717 (16-18 hours vrs 8-10 hours). So while CX-717 may be a once/day drug, CX-701 can definitely be once/day.
It sounded like CX-1763 came out the new chemical groups just patented earlier this year (I think associated with the new chemist Dr. Street).
There was a several minute gap in the webcast on my end, so I'll have to re-listen to get additional details. As others mentioned, I think Stoll was saving the last 5 minutes for questions, but the moderator thought the time was up. I think we'll get a conf call within the next week though for our own Q+As.
Market Data 
Markets 
AI
